Clinical Stage IV Gastric Cancer AJCC v8 Recruiting Phase 1 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0113387 (Clinical Stage IV Gastric Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05269381Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsTreatment